Jpmorgan Chase & Co »

Lyra Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $174k 33k 5.24
2023-09-30 $133 34 3.91
2023-06-30 $139 34 4.12
2023-03-31 $0 34 0.00
2022-12-31 $0 34 0.00
2022-06-30 $0 34 0.00
2022-03-31 $31k 7.8k 4.01
2021-12-31 $0 849 0.00
2021-03-31 $1.7M 147k 11.59
2020-12-31 $2.2M 191k 11.41
2020-09-30 $23k 1.9k 11.76
2020-06-30 $37k 3.4k 11.14